Learn on Demand

Knowledge Gap: 
The purpose of this activity is to educate healthcare providers with the most up-to-date information on Considerations in Outpatient Pain Management for Sickle Cell Disease.

Target Audience
The target audience includes all healthcare professionals such as physicians, nurses, pharmacists and allied health professionals who would like to learn about Considerations in Outpatient Pain Management for Sickle Cell Disease and how it pertains to their respective profession.

 
Release and Expiration Dates
9/22/2017 -9/22/2020

Objectives

References:·    
• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. The Journal of Pain. 2015;16(8): 769-780.
• Glowacki D. Effective pain management and improvements in patients’ outcomes and satisfaction. Critical Care Nurse. 2015;35(3): 33-42.
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States 2016. JAMA. 2016;315(15): 1624-1645. doi:10.1001/jama.2016.1464
• McCaffery M. Nursing Practice Theories Related to Cognition, Bodily Pain, and Man-environment interactions. Los Angeles, CA: UCLA Students’ Store; 1968.
• https://www.census.gov/quickfacts/table/PST045215/00. Accessed May 13, 2016.
• Chou R, Deyo R, Devine B, et al. The effectiveness and risks of long-term opioid treatment of chronic pain [Evidence Report/Technology Assessment N. 218]. Agency for Healthcare and Quality. http://www.effectivehealthcare.ahrq.gov/ehc/products/557/1971/chronic-pain-opioid-treatment-report-141007.pdf. Accessed May 13, 2016.
• Guideline for the use of chronic opioid therapy in chronic noncancer pain: evidence review. American Pain Society and American Academy of Pain Medicine. http://americanpainsociety.org/uploads/education/guidelines/chronic-opioid-therapy-cncp.pdf. Accessed May 13, 2016
• http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm395456.htm
• Chronic pain: symptoms, diagnosis, & treatment. NIH Medline Plus. 2011;6(1): 5-6. https://www.nlm.nih.gov/medlineplus/magazine/issues/spring11/articles/spring11pg5-6.html. Accessed May 17, 2016
• http://www.arkansaspmp.com/
• Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Rosenblum A, et al. Exp Clin Psychopharmacol. Oct 2008; 6(5): 405-16. Accessed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711509
• McCain K, Cullen, J, King J, Foster H. Aransas Illicit Opioid Crisis. APA Annual Convention. June 2016. [Poster]
• Nihara Y, Zerez CR, Akiyama DS, et al. Oral l-glutamine therapy for sickle cell anemia: subjective clinical improvement and favorable change in red cell NAD redox potential. Am J Hematol. 1998;58(2): 117-121.

Biographical Info

Lindsey Dayer, PharmD, BCACP is currently on faculty as an Assistant Professor of Pharmacy Practice. Her clinical practice sites are within the Winthrop P. Rockefeller Cancer Institute and are the Medical Oncology and Palliative Care Clinics.  She received her PharmD from the University of Arkansas for Medical Sciences in 2009, completed a Pharmacy Practice Residency at UAMS in 2010, and joined the College of Pharmacy faculty in 2010. Her research interests include: pharmacist-directed interventions to improve adherence to medications, specifically oral antineoplastic agents, interventions to improve patient education and promote patient self-efficacy regarding their oral medications, and quality of life related outcomes in patients with cancer and pain related to their disease.

Speaker Disclosures:
The planners, speakers, moderators, peer reviewers and /or panelists of this CE activity have no relevant financial relationships with commercial interests to disclose.

Planners: 
Kim Miller  
Susan Smith Dodson
Mark Jansen

Speaker:
Lindsey Dayer, PharmD, BCACP

Peer Reviewers: 
Kim Miller, MCHES